You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

411 Results
Drug
Other Name(s): Uromitexan® (multiple brands available)
Nov 2017
Drug
Other Name(s): Mutamycin® (generic brand available)
May 2018
Drug
Other Name(s): Sutent®
Sep 2023
Drug
Other Name(s): Provera® (multiple brands available)
Apr 2015
Drug
Other Name(s): Megace® (multiple brands available)
Aug 2016
Drug
Other Name(s): Purinethol®
Jun 2019
Drug
Other Name(s): Lysodren®
Jun 2019
Drug
Other Name(s): Novantrone® (multiple brands available)
May 2018
Drug
Drug
Other Name(s): Sylvant®
Mar 2025
Drug
Other Name(s): Rydapt®
Jun 2025
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Palliative
Funding:
Exceptional Access Program
    SUNItinib - Unresectable or metastatic/recurrent Gastrointestinal Stromal Tumour, with specific criteria
Oct 2020

Pages